ArticleScientific reports2025

PARP inhibitor and PRMT5 inhibitor synergy is independent of BRCA1/2 and MTAP status in breast cancer cells.

Samyuktha Suresh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.